NovaBay Expands Global Ophthalmology Study of Pink Eye to India

NovaBay Expands Global Ophthalmology Study of Pink Eye to India

[at noodls] – Phase 2b BAYnovation Study for the Treatment of Viral Conjunctivitis Includes 60 Clinical Sites Worldwide EMERYVILLE, CA – January 3, 2013 – NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology … more

View todays social media effects on NBY

View the latest stocks trending across Twitter. Click to view dashboard

See who NovaBay is hiring next, click here to view

Share this post